Birdwatch Note
2023-04-19 01:16:13 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Tweet contains misleading info. The FDA announced that the bivalent vaccines are now to be used for all doses rather than the original monovalent vaccines. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-changes-simplify-use-bivalent-mrna-covid-19-vaccines
Written by FA634FD74F442746A3DB016383AC908445C99DF9C084E82CCBA0FFD096553AD5
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1648471877265035264
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1648495685707210752
- noteId - 1648495685707210752
- participantId -
- noteAuthorParticipantId - FA634FD74F442746A3DB016383AC908445C99DF9C084E82CCBA0FFD096553AD5 Participant Details
- createdAtMillis - 1681866973698
- tweetId - 1648471877265035264
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Tweet contains misleading info. The FDA announced that the bivalent vaccines are now to be used for all doses rather than the original monovalent vaccines. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-changes-simplify-use-bivalent-mrna-covid-19-vaccines
Note Ratings
| rated at | rated by | |
| 2023-04-18 20:25:11 -0500 | Rating Details | |
| 2023-04-19 05:08:21 -0500 | Rating Details | |
| 2023-04-18 20:39:48 -0500 | Rating Details | |
| 2023-04-19 12:07:33 -0500 | Rating Details | |
| 2023-04-18 21:26:25 -0500 | Rating Details | |
| 2023-04-19 01:28:28 -0500 | Rating Details | |
| 2023-04-18 21:49:20 -0500 | Rating Details | |
| 2023-04-19 00:33:49 -0500 | Rating Details | |
| 2023-04-19 00:02:33 -0500 | Rating Details | |
| 2023-04-19 03:24:01 -0500 | Rating Details | |
| 2023-04-18 21:13:58 -0500 | Rating Details | |
| 2023-04-19 02:19:45 -0500 | Rating Details | |
| 2023-04-18 20:25:11 -0500 | Rating Details | |
| 2023-04-19 05:08:21 -0500 | Rating Details | |
| 2023-04-18 20:39:48 -0500 | Rating Details | |
| 2023-04-19 12:07:33 -0500 | Rating Details | |
| 2023-04-18 21:26:25 -0500 | Rating Details | |
| 2023-04-19 01:28:28 -0500 | Rating Details | |
| 2023-04-18 21:49:20 -0500 | Rating Details | |
| 2023-04-19 00:33:49 -0500 | Rating Details | |
| 2023-04-19 00:02:33 -0500 | Rating Details | |
| 2023-04-19 03:24:01 -0500 | Rating Details | |
| 2023-04-18 21:13:58 -0500 | Rating Details | |
| 2023-04-19 02:19:45 -0500 | Rating Details |